Micafungin Viatris

Micafungin, the active ingredient in Micafungin Viatris, is an echinocandin presented as a intravenous solution for intravenous use. It treats invasive fungal infections such as candidemia, esophageal candidiasis, and is used for prophylaxis in hematopoietic stem cell transplantation.

GNH USA supplies Micafungin Viatris as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Micafungin is an echinocandin antifungal that targets the fungal cell wall.

- Invasive candidiasis: effective in treating bloodstream and deep‑tissue Candida infections. - Esophageal candidiasis: resolves mucosal infection of the esophagus caused by Candida species. - Candidemia: clears Candida organisms from the blood stream. - Prophylaxis in hematopoietic stem cell transplantation: prevents invasive fungal infections in transplant recipients.

Micafungin may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Elevated liver enzymes: transient increase in ALT or AST. - Fever: mild to moderate temperature rise. - Nausea: occasional gastrointestinal discomfort. - Headache: mild headache episodes.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury requiring monitoring. - Hypersensitivity reactions: rash, pruritus, or anaphylaxis. - Infusion‑related reactions: hypotension, dyspnea, or chest pain. - Renal impairment: acute kidney injury in susceptible patients.

When prescribing Micafungin, clinicians should consider several precautionary measures to ensure safe use.

- Liver function monitoring: assess baseline transaminases and repeat during therapy. - Renal function assessment: evaluate creatinine clearance before and during treatment. - Drug interactions: review concomitant medications that affect hepatic metabolism. - Pregnancy and lactation: use only if potential benefit justifies risk, as safety data are limited. - Pediatric use: adjust dosing based on weight and clinical condition; follow specialist guidance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Cytochrome P450 inducers (e.g., rifampin, carbamazepine): may reduce micafungin exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase micafungin levels, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Immunosuppressants (e.g., tacrolimus, cyclosporine): may require dose adjustment. - Antifungal agents (e.g., azoles): overlapping toxicity, monitor liver function. - Warfarin: potential alteration of anticoagulant effect, monitor INR.